These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8648742)

  • 1. Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions.
    Chambers MA; Dougan G; Newman J; Brown F; Crowther J; Mould AP; Humphries MJ; Francis MJ; Clarke B; Brown AL; Rowlands D
    J Virol; 1996 Jun; 70(6):4045-52. PubMed ID: 8648742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific interactions between human integrin alpha v beta 3 and chimeric hepatitis B virus core particles bearing the receptor-binding epitope of foot-and-mouth disease virus.
    Sharma A; Rao Z; Fry E; Booth T; Jones EY; Rowlands DJ; Simmons DL; Stuart DI
    Virology; 1997 Dec; 239(1):150-7. PubMed ID: 9426454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.
    Jackson T; Sharma A; Ghazaleh RA; Blakemore WE; Ellard FM; Simmons DL; Newman JW; Stuart DI; King AM
    J Virol; 1997 Nov; 71(11):8357-61. PubMed ID: 9343190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells.
    Berinstein A; Roivainen M; Hovi T; Mason PW; Baxt B
    J Virol; 1995 Apr; 69(4):2664-6. PubMed ID: 7533862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
    Yin Y; Zhang J; Dong D; Liu S; Guo Q; Song X; Li G; Fu L; Xu J; Chen W
    Vaccine; 2008 Oct; 26(46):5814-21. PubMed ID: 18786589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus.
    Jackson T; Sheppard D; Denyer M; Blakemore W; King AM
    J Virol; 2000 Jun; 74(11):4949-56. PubMed ID: 10799568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors.
    Villaverde A; Feliu JX; Harbottle RP; Benito A; Coutelle C
    Gene; 1996 Nov; 180(1-2):101-6. PubMed ID: 8973352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.
    Baranowski E; Ruiz-Jarabo CM; Sevilla N; Andreu D; Beck E; Domingo E
    J Virol; 2000 Feb; 74(4):1641-7. PubMed ID: 10644333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
    J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5beta1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding.
    Jackson T; Blakemore W; Newman JW; Knowles NJ; Mould AP; Humphries MJ; King AM
    J Gen Virol; 2000 May; 81(Pt 5):1383-91. PubMed ID: 10769082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif.
    Ruiz-Jarabo CM; Sevilla N; Dávila M; Gómez-Mariano G; Baranowski E; Domingo E
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():1899-1909. PubMed ID: 10466785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
    Grigera PR; Garcia-Briones M; Periolo O; la Torre JL; Wagner RR
    J Virol; 1996 Dec; 70(12):8492-501. PubMed ID: 8970972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells.
    Tan BH; Nason E; Staeuber N; Jiang W; Monastryrskaya K; Roy P
    J Virol; 2001 Apr; 75(8):3937-47. PubMed ID: 11264382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.
    Rieder E; Berinstein A; Baxt B; Kang A; Mason PW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10428-33. PubMed ID: 8816817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
    Clarke BE; Newton SE; Carroll AR; Francis MJ; Appleyard G; Syred AD; Highfield PE; Rowlands DJ; Brown F
    Nature; 1987 Nov 26-Dec 2; 330(6146):381-4. PubMed ID: 2446137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
    Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH
    Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection.
    Jackson T; Clark S; Berryman S; Burman A; Cambier S; Mu D; Nishimura S; King AM
    J Virol; 2004 May; 78(9):4533-40. PubMed ID: 15078934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of foot-and-mouth disease virus grown in BHK-21 suspension cells. Correlation with cell ploidy alterations and abnormal expression of the alpha 5 beta 1 integrin.
    Amadori M; Berneri C; Archetti IL
    Vaccine; 1994 Feb; 12(2):159-66. PubMed ID: 7511862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
    Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
    Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit.
    Neff S; Mason PW; Baxt B
    J Virol; 2000 Aug; 74(16):7298-306. PubMed ID: 10906183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.